Vir Biotechnology (NASDAQ:VIR) Sets New 12-Month Low at $12.10

Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) hit a new 52-week low on Tuesday . The stock traded as low as $12.10 and last traded at $12.15, with a volume of 320691 shares trading hands. The stock had previously closed at $12.51. Analysts Set New Price Targets Several equities research analysts have […]

Related Keywords

,Vickil Sato ,Barclays ,Nasdaq ,Vir Biotechnology Inc ,Brandywine Global Investment Management ,Needham Company ,Jennison Associates ,Goldman Sachs Group ,Endurance Cayman Ltd Svf ,Securities Exchange Commission ,Barclays Plc ,Morgan Stanley ,Vir Biotechnology ,Get Free Report ,Ltd Svf ,Director Vicki ,Exchange Commission ,Global Investment Management ,Technologies Capital Management ,Vir Biotechnology Daily ,Nasdaq Vir ,Ivir ,Medical ,Stocks ,Technicals ,